Immunomodulation to enhance the efficacy of an HPV therapeutic vaccine

Overview of attention for article published in Journal for Immunotherapy of Cancer, June 2020

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
Among the highest-scoring outputs from this source (#48 of 3,426)
High Attention Score compared to outputs of the same age (97th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 38 news stories from 21 outlets.

Summary PDS0101, an innovative immunotherapy, targets HPV-positive cancers, including recurrent or metastatic head and neck…

By: GlobenewsWire - 24 May 2021 FLORHAM PARK, N.J., May 24, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB…

FLORHAM PARK, N.J., May 24, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-stage…

(GLOBE NEWSWIRE) FLORHAM PARK, N.J., May 24, 2021 (GLOBE NEWSWIRE) -- PDS Biotechnology Corporation (Nasdaq: PDSB), a clinical-st…

This page shows the most recent news stories that mention this research output.

Click here to find out how to access more activity, including 34 additional news stories.